Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03972163 · ClinicalTrials.gov registry record · NA
Standardized Patient-Centered Medication Review in Home Hospice
A NA study of Palliative Care and Caregivers, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03972163: Completed NA study of Palliative Care and Caregivers, sponsored by University of Massachusetts, Worcester.
NCT03972163 is a NA study of Palliative Care and Caregivers that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 23 participants, below the 1,415-participant average among 18 other Palliative Care trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03972163, a NA study of Palliative Care and Caregivers, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot cluster randomized trial that tests the effect of a novel intervention that trains hospice staff to 1. regularly review, simplify, and align patients' prescribed medications with their goals of care as their illness progresses, and 2. support family caregivers with education that empowers them to understand each medication's use, develop skills for safe administration, and 3. understand when stopping medications may be beneficial.
Primary Outcome
Number of Completed Intervention Trainings
Conditions Studied
Interventions
- BEHAVIORAL NIA Medication Management - Active Comparator
- BEHAVIORAL STOPPFrail (Screening Tool of Older Persons Prescriptions)
- BEHAVIORAL "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing"
- BEHAVIORAL "Key Approaches to Support Informal Family Caregivers in Managing Medications"
Study Locations (1)
Massachusetts
- Care Dimensions - Danvers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03972163 record still lists
NCT03972163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,415-participant average among 18 other Palliative Care trials with a reported enrollment target (98% lower).
The record links to 7 conditions, with Palliative Care appearing as the primary indexed condition, and to 4 interventions - of which NIA Medication Management - Active Comparator is the first listed.
NCT03972163 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03972163 about?
NCT03972163 is a clinical study titled "Standardized Patient-Centered Medication Review in Home Hospice". This is a pilot cluster randomized trial that tests the effect of a novel intervention that trains hospice staff to 1. regularly review, simplify, and align patients' prescribed medications with their goals of care as their illness progresses, and 2. support family caregivers with education that emp...
What is the current status of trial NCT03972163?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-01-15. Estimated completion is 2023-12-31.
What conditions does trial NCT03972163 study?
This clinical trial studies the following conditions: Palliative Care, Caregivers, Polypharmacy, Interdisciplinary Communication, Hospices.
What interventions are being tested in trial NCT03972163?
The interventions under investigation include: NIA Medication Management - Active Comparator (BEHAVIORAL), STOPPFrail (Screening Tool of Older Persons Prescriptions) (BEHAVIORAL), "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing" (BEHAVIORAL), "Key Approaches to Support Informal Family Caregivers in Managing Medications" (BEHAVIORAL).
Who is sponsoring clinical trial NCT03972163?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03972163 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Palliative Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03972163's enrollment target sits among peer trials
23 18th of 18 higher than 1 of 18 other Palliative Care trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Palliative Care trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Needs Among Older Adults
RECRUITING · NA
-
Patient-centered, Optimal Integration of Survivorship and Palliative Care
RECRUITING · NA
-
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
RECRUITING · NA
-
Comparing the Stanford Letter Project Form to Traditional Advance Directives
RECRUITING · NA
-
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
RECRUITING · NA
-
A Pragmatic Trial of an Active Choice Nudge for Generalist or Specialist Palliative Care for Seriously Ill Inpatients
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI